在系统回顾、梳理清宣止咳颗粒上市以来的临床及基础研究成果的基础上，采用国际临床医学专家共识研制方法，通过召开专家论证会及函审，结合现有循证证据制定本专家共识。共识对清宣止咳颗粒治疗儿童感冒、支气管炎的优势环节、给药方案与剂量疗程特点、安全性问题等进行了推荐或建议，并通过专家会议以及函审的方式，在全国范围内进行意见征求和同行评议，可为指导清宣止咳颗粒的临床合理用药提供参考。

On the basis of systematic review and sorting out the clinical and basic research achievements of Qingxuan Zhike Granule since its listing, the international clinical medical expert consensus development method was adopted. This expert consensus was developed by holding expert review meetings and letter reviews, combined with existing evidence-based evidence. This consensus has recommended or suggested the advantages of Qingxuan Zhike Granule in treating children's colds and bronchitis, the characteristics of drug delivery scheme and dosage course, and safety issues, and has solicited opinions and peer reviews nationwide through expert meetings and letter reviews, which can provide reference for guiding the rational clini‐ cal use of Qingxuan Zhike Granule.

R285.5